ロード中...
Real-World Use – Isavuconazole at a Large Academic Medical Center
BACKGROUND: Invasive fungal infections cause significant mortality and morbidity. Isavuconazole (ISV) is a new triazole approved for treatment of mucormycosis and aspergillosis. Data on its effectiveness outside clinical trials and in patients receiving prior triazole prophylaxis are lacking. METHOD...
保存先:
| 出版年: | Open Forum Infect Dis |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5631743/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.028 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|